Subcutaneous Immunotherapy Improves the Symptomatology of XXXX .

@entity1 @entity5254 @entity2023
Introduction   The relevance of @entity2023 is unquestionable. This condition affects @entity1 's quality of life and its incidence has increased over the last years. Objective   Thus, this study aims to analyze the effectiveness of subcutaneous injectable immunotherapy in cases of nasal itching, sneeze, @entity5254 and nasal congestion in @entity2023 @entity1 . Methods   In the present study, the same researcher analyzed the records of 281 @entity1 . Furthermore, the researchers identified allergens through puncture cutaneous tests using standardized extracts containing acari, fungi, pet hair, flower pollen, and feathers. Then, the @entity1 underwent treatment with subcutaneous specific immunotherapy, using four vaccine vials for desensitization, associated with environmental hygiene. The authors analyzed conditions of nasal itching, sneeze, @entity5254 , and nasal congestion throughout the treatment, and assigned them with a score ranging from zero (0), meaning absence of these symptoms to three (3), for severe cases. The symptoms were statistically compared in the beginning, during, and after treatment. Results   In this study, authors analyzed the cases distribution according to age and the evolution of symptomatology according to the scores, comparing all phases of treatment. The average score for the entire population studied was 2.08 before treatment and 0.44 at the end. These results represent an overall improvement of    79% in symptomatology of @entity2023 in the studied population. Conclusion   The subcutaneous immunotherapy as treatment of @entity2023 led to a reduction in all symptoms studied, improving the quality of life of @entity1 , proving itself as an important therapeutic tool for these pathological conditions.
